Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022
PDF Version

 

In an interview, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.


 

Advertisement

Advertisement

Advertisement